None of the breast cancer cell lines, however, were able to induce signalling of the chimeric Siglec‐9 receptor, while Siglec‐9 antibodies and a Siglec‐9 ligand containing polymer used as a positive controls readily induced chSiglec‐9 signalling in these cells. This evidence concerns the gene SIGLEC9 and breast carcinoma.